Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron
January 25, 2022 at 06:45 AM EST
Pfizer CEO Albert Bourla has said the company will have the omicron vaccine ready by March.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.